Bavarian Nordics mpox-vaccine anbefales til rutinemæssig brug i risikogrupper af de amerikanske sundhedsmyndigheders rådgivningskomité
October 25, 2023 14:03 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 25. oktober 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at den rådgivende vaccinekomité (ACIP) hos det det amerikanske center for infektionsforebyggelse og folkesundhed...
Bavarian Nordic’s Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk
October 25, 2023 14:03 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, October 25, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices...
Bavarian Nordic tildelt yderligere kontrakt om levering af koppevacciner til strategisk lager i EU
September 13, 2023 05:33 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 13. september 2023 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået yderligere en kontrakt til en værdi af mere end EUR 11 mio. på levering af MVA-BN®...
Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve
September 13, 2023 05:33 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract valued at more than EUR 11 million to supply its MVA-BN® smallpox...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
September 04, 2023 08:06 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 4. september 2023 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
September 04, 2023 08:06 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 4, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
September 01, 2023 07:09 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 1. september 2023 – Bavarian Nordic A/S (OMX: BAVA) har dags dato modtaget oplysninger om følgende transaktioner med selskabets aktie/tilknyttede værdipapirer, foretaget af ledende...
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
September 01, 2023 07:09 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, September 1, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding...
Bavarian Nordic opdaterer på programmet for COVID-19 boostervaccine
August 31, 2023 11:08 ET
|
Bavarian Nordic A/S
ABNCoV2 og vaccinen, der blev sammenlignet med, viste reducerede niveauer af neutraliserende antistoffer mod en cirkulerende variant (omikron XBB.1.5) i fase 3-forsøget.cVLP-platformen har påvist...
Bavarian Nordic Provides Update on COVID-19 Booster Vaccine Program
August 31, 2023 11:08 ET
|
Bavarian Nordic A/S
ABNCoV2 and the comparator vaccine demonstrated a reduced level of neutralizing antibodies against a circulating variant (Omicron XBB.1.5) in Phase 3 study.cVLP platform has proven its ability to...